Sagimet Biosciences Inc. (SGMT) stock analysis

In our weekly check, Sagimet Biosciences Inc. is graded F (A to F). Of 18 checks on debt, profit, cash flow and trend: 4 pass, warnings: 3, red flags: 11.

About Sagimet Biosciences Inc.

Sagimet Biosciences Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as SGMT.

What our checks show for SGMT

Red flags

• Weak EPS forecast
• Analysts expect the net margin to shrink by 237 points from today's 0%.
• Earnings per share fell 2.5% a year over the last 3 years.
• The net margin is only 0%: little room if costs rise.
• Free cash flow is negative (-4132200000% of revenue): the business spends more cash than it brings in.
• The price swings a lot: 79.4% annual volatility. Expect large ups and downs.
• The stock has fallen as much as 90% from a peak. Would you have held through that?
• Beta 3.49: the stock usually moves more than the market, both up and down.
• The share count grew by 77.8% in 2 years: each shareholder owns a smaller slice.
• Return on capital (ROCE) is zero or negative: the business does not earn on the money put into it.
• Pay in shares equals 0% of free cash flow: it dilutes shareholders.

Warning signs

• Operating cash flow is negative while the company reports a profit: the profit does not arrive as cash.
• A small company (market value $312 million): usually riskier and followed by fewer analysts.
• The stock is still below its previous peak.

Strengths

• Debt is low: 0.01x equity.

Next earnings report: 2026-11-12

Similar companies

XFOR · BNTC · KYTX · OBIO · IRD · MPLT

Questions

What grade does Sagimet Biosciences Inc. (SGMT) have?

In our weekly check, Sagimet Biosciences Inc. is graded F (A to F). Of 18 checks on debt, profit, cash flow and trend: 4 pass, warnings: 3, red flags: 11. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of SGMT stock?

This week's biggest flags for Sagimet Biosciences Inc.: Weak EPS forecast, Margins expected to shrink, Weak EPS growth. In total 14 of 18 checks show a warning or a red flag.

What does Sagimet Biosciences Inc. do?

Sagimet Biosciences Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as SGMT.

When does Sagimet Biosciences Inc. report earnings next?

The next earnings report is expected on 2026-11-12. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis